Skip to main content

Advertisement

Log in

A case of early recurrent immunoglobulin A nephropathy and T-cell-mediated rejection in a transplant patient with Wiskott–Aldrich syndrome

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Wiskott–Aldrich syndrome (WAS) is an X-chromosome recessive immunodeficiency disease characterized by the triad of thrombocytopenia, eczema, and susceptibility to infection owing to WAS protein gene abnormalities. Kidney transplantation is rarely offered to WAS patients with end-stage renal disease because of concerns that thrombocytopenia and immune disorders may affect the clinical outcome. Here, we report the case of a 20-year-old kidney transplant patient who developed end-stage renal disease owing to immunoglobulin (Ig)A nephropathy caused by WAS. Despite recurrent IgA nephropathy and T-cell-mediated rejection 7 months after transplantation, two rounds of steroid pulse therapy attenuated his renal function and urinary abnormality. His serum creatinine level was maintained at approximately 1.5 mg/dL 1 year after transplantation. No other WAS-related complications were observed throughout the clinical course. Although WAS can cause poor prognosis in kidney transplant patients, careful follow-up may allow kidney transplantation to be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Malik MA, Masab M. Wiskott-Aldrich syndrome. Treasure Island (FL): StatPearls Publishing LLC; 2021.

    Google Scholar 

  2. Liu C-H, Wu K-H, Lin T-Y, Wei C-C, Lin C-Y, Chen X-X, et al. Wiskott-Aldrich syndrome with IgA nephropathy: a case report and literature review. Int Urol Nephrol. 2013;45:1495–500.

    Article  Google Scholar 

  3. Chovancova Z, Kuman M, Vlkova M, Litzman J. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation. Transpl Int. 2015;28:1005–9.

    Article  Google Scholar 

  4. Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott-Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers. 2010;29:157–75.

    Article  CAS  Google Scholar 

  5. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622–7.

    Article  Google Scholar 

  6. Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.

    Article  CAS  Google Scholar 

  7. Blosser CD, Bloom RD. Recurrent glomerular disease after kidney transplantation. Curr Opin Nephrol Hypertens. 2017;26:501–8.

    Article  Google Scholar 

  8. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation. 1998;65:1053–60.

    Article  CAS  Google Scholar 

  9. Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, et al. Early recurrence of active IgA nephropathy after kidney transplantation. Nephrology. 2014;19:45–8.

    Article  Google Scholar 

  10. Park S, Baek CH, Cho H, Yu MY, Kim YC, Go H, et al. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy. Am J Transplantat. 2019;19:145–55.

    Article  Google Scholar 

  11. Floege J, Grone HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transplant. 2013;28:1070–3.

    Article  Google Scholar 

  12. Meisels IS, Strom TB, Roy-Chaudhury P, Abrams J, Shapiro ME. Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome. Transplantation. 1995;59:1214–5.

    Article  CAS  Google Scholar 

  13. Fischer A, Binet I, Oertli D, Bock A, Thiel G. Fatal outcome of renal transplantation in a patient with the Wiskott-Aldrich syndrome. Nephrol Dial Transplant. 1996;11:2077–9.

    Article  CAS  Google Scholar 

  14. Maillard MH, Cotta-De-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. J Exp Med. 2007;204:381–91.

    Article  CAS  Google Scholar 

  15. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345–52.

    Article  CAS  Google Scholar 

  16. Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN. The clinical course of IgA nephropathy after kidney transplantation and its management. Transplant Rev (Orlando). 2017;31:106–14.

    Article  Google Scholar 

  17. Kakio Y, Uchida HA, Kitagawa M, Arata Y, Kato A, Inoue-Torii A, et al. IgA nephropathy complicated with X-linked thrombocytopenia. Acta Med Okayama. 2018;72:301–7.

    CAS  PubMed  Google Scholar 

  18. Tomiyoshi Y, Sakemi T, Ikeda Y, Ohtsuka Y, Nakamura M, Fujisaki T. Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy. Intern Med. 2001;40:862–6.

    Article  CAS  Google Scholar 

  19. Webb MC, Andrews PA, Koffman CG, Cameron JS. Renal transplantation in Wiskott-Aldrich syndrome. Transplantation. 1993;56:1585.

    CAS  PubMed  Google Scholar 

  20. Garnier AS, Augusto JF, Pellier I, Subra JF, Sayegh J. Successful long-term outcome of kidney transplantation in a patient with X-linked thrombocytopenia: 9 year follow-up. Transplantation. 2014;98:e57–8.

    Article  Google Scholar 

  21. Kai K, Sumida M, Motoyoshi Y, Ogawa Y, Miki K, Iwadoh K, et al. Successful long-term graft survival of a renal transplantation patient with Wiskott-Aldrich syndrome. Intern Med. 2016;55:1761–3.

    Article  Google Scholar 

  22. Al Midani A, Donohue C, Berry P, Jones G, Fernando B. Use of thromboelastography to guide platelet infusion in a patient with Wiskott-Aldrich syndrome undergoing renal transplant. Exp Clin Transplant. 2020;18:636–7.

    Article  Google Scholar 

Download references

Acknowledgements

The pathological findings of this case were diagnosed by Dr. Takashi Taguchi and Dr. Satoshi Hisano. Unfortunately, both have since passed away.

Funding

The authors received no specific funding for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mineaki Kitamura.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

The present report and all procedures described in it have been carried out in accordance with the 1964 Declaration of Helsinki and its later amendments.

Informed consent

The patient provided a signed informed consent form for publication of the case report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamaguchi, K., Kitamura, M., Kawaguchi, Y. et al. A case of early recurrent immunoglobulin A nephropathy and T-cell-mediated rejection in a transplant patient with Wiskott–Aldrich syndrome. CEN Case Rep 11, 60–66 (2022). https://doi.org/10.1007/s13730-021-00631-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-021-00631-9

Keywords

Navigation